Leicester, United Kingdom
Velocity Clinical Research, Leicester
Founded in 2023 as one of Velocity Clinical Research’s first greenfield sites in the U.K., the experienced team at Velocity’s dedicated research site in Leicester conducts Phase 2-4 clinical trials across a broad variety of indications, including vaccines as well as medicines developed to treat migraines, diabetes, acne, depression, high cholesterol, and other conditions. By developing strong working relationships with local communities and having close ties with networks of cooperating practices, Velocity’s Leicester staff provides fast, accurate patient enrollment support, even for diverse populations.
Our Leicester team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research. With decades of research experience shared among our investigators in Leicester, Velocity will deliver the right patients, investigators, and research staff for your next research program.
Velocity Clinical Research, Leicester
St Johns House, 30 East Street, Leicester LE1 6NB
Phone: +44 11650 30406
Find a Clinical Trial in Leicester
Browse current research studies in Leicester on VelocityClinicalTrials.eu.
Our experienced research team in Leicester
Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Leicester is dedicated to conducting quality research in a professional and caring environment.
-
Principal Investigator
Dr. Fisher graduated from Bristol Medical School in 2015 and worked as a physician in general and emergency medicine for five years in the NHS. During this period, he also completed a Graduate Diploma in Law and was an NHS Innovation Fellow. Dr Fisher started in clinical development nearly five years ago and has worked for both a Sponsor and CRO. He has led clinical trials in ATTR Amyloidosis from Phase 1-3 for CROs and was involved with regulatory submissions, protocol development, and early-stage clinical development strategy at the Sponsor level.
Sponsors and CROs
From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.
